Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone‐induced demyelination mouse model
- 10 January 2019
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (6), 10576-10586
- https://doi.org/10.1002/jcb.28344
Abstract
Multiple sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system (CNS). Despite introducing multiple immunomodulatory approaches for MS, there are still major concerns about possible ways for improving remyelination in this disease. Microglia exert essential roles in regulation of myelination processes, and interaction between colony‐stimulating factor 1 (CSF1) with its receptor CSF1R is considered as a key regulator of microglial differentiation and survival. The aim of this study was to investigate possible roles for a CSF1R inhibitor PLX3397 in recovery of central myelination processes. Chronic demyelination was induced in mice by addition of 0.2% cuprizone to the chow for 12 weeks. Next, animals were undergoing a diet containing 290 mg/kg PLX3397 to induce microglial ablation. The PLX3397 treatment caused a significant decrease in the rate of expression for the CSF1/CSF1R axis, and a reduction in the protein expressions for the microglial marker Iba‐1 and for the oligodendrocyte marker Olig‐2. Findings from Luxol fast blue (LFB) staining and transmission electron microscopy (TEM) showed an increase in the rate of myelination for the mice receiving PLX3397. The rate of destruction in the nerve fibers and the extent of the gaps formed between layers of myelin sheaths was also reduced after the treatment with PLX3397. In addition, animals experienced an improvement in recovery of motor deficit after receiving PLX3397 (for all P < 0.05). It could be concluded that PLX3397 could retain myelination in the MS model possibly through regulation of the myelin environment.Keywords
Funding Information
- Tehran University of Medical Sciences and Health Services (95.04.30‐33645)
This publication has 53 references indexed in Scilit:
- Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945Acta Neuropathologica Communications, 2018
- Inflammasome: Its role in traumatic brain and spinal cord injuryJournal of Cellular Physiology, 2017
- Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on MicrogliaNeurochemical Research, 2017
- Laquinimod prevents cuprizone-induced demyelination independent of Toll-like receptor signalingNeurology Neuroimmunology & Neuroinflammation, 2016
- Genetic Cell Ablation Reveals Clusters of Local Self-Renewing Microglia in the Mammalian Central Nervous SystemImmunity, 2015
- Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell deathNature Reviews Molecular Cell Biology, 2013
- The Benefits and Detriments of Macrophages/Microglia in Models of Multiple SclerosisJournal of Immunology Research, 2013
- A critical appraisal of treatment decisions in multiple sclerosis—old versus newNature Reviews Neurology, 2011
- Microglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled PhagocytosisCell Stem Cell, 2010
- Neurotoxicity by microglia: Mechanisms and potential therapeutic strategyClinical and Experimental Neuroimmunology, 2010